Clinical Outcomes Following a Change in Gestational Diabetes Mellitus Diagnostic Criteria Due to the COVID-19 Pandemic: A Case-Control Study

Niamh Keating, Kirsten Carpenter, Kelsey McCarthy, Ciara Coveney, Fionnuala McAuliffe, Rhona Mahony, Jennifer Walsh, Mensud Hatunic and Mary Higgins
Additional contact information
Niamh Keating: UCD Perinatal Research Centre, National Maternity Hospital, University College Dublin, 4 Dublin, Ireland
Kirsten Carpenter: UCD School of Medicine, 4 Dublin, Ireland
Kelsey McCarthy: UCD School of Medicine, 4 Dublin, Ireland
Ciara Coveney: Department of Midwifery, National Maternity Hospital, 2 Dublin, Ireland
Fionnuala McAuliffe: UCD Perinatal Research Centre, National Maternity Hospital, University College Dublin, 4 Dublin, Ireland
Rhona Mahony: Obstetrics and Gynaecology, National Maternity Hospital, 2 Dublin, Ireland
Jennifer Walsh: UCD Perinatal Research Centre, National Maternity Hospital, University College Dublin, 4 Dublin, Ireland
Mensud Hatunic: Department of Endocrinology, Mater Misericordiae Hospital, 7 Dublin, Ireland
Mary Higgins: UCD Perinatal Research Centre, National Maternity Hospital, University College Dublin, 4 Dublin, Ireland

IJERPH, 2022, vol. 19, issue 3, 1-10

Abstract: Background: Due to COVID-19, many centres adopted a change to the diagnosis of GDM. Methods: A case-control study of antenatal patients between 1 April and 30 June in 2019 and 2020 looking at detection rates of GDM, use of medication, obstetric, and fetal outcomes. Results: During COVID-19, the rate of positive GDM tests approximately halved (20% (42/210) in 2020 vs. 42.2% (92/218) in 2019, ( p < 0.01)) with higher rates of requirement for insulin at diagnosis (21.4% (2020) vs. 2.2% (2019); p < 0.01), and at term (31% (2020) vs. 5.4% (2019); p < 0.01). and metformin at diagnosis (4.8% (2020) vs. 1.1% (2019); p < 0.01), and at term (14.3% (2020) vs. 7.6% (2019) p < 0.01), with no differences in birth outcomes. Conclusions: There was likely an underdiagnosis of GDM while women at a higher risk of hyperglycaemia were correctly identified. The GTT should be maintained as the gold-standard test where possible, with provisions made for social distancing during testing if required.

Keywords: COVID-19; gestational diabetes mellitus; antenatal care (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/3/1884/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/3/1884/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:3:p:1884-:d:744248

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().